Japan Pharmaceuticals & Healthcare Report Q3 2014 - New Report Available
BMI View: The Japanese government's push to increase generic drug use will benefit generic drug manufacturers, particularly local firms. However, despite this support, the rate of generic drug uptake will remain relatively low. As a result our forecasts for Japan's generic drug market are unchanged. In its FY2014 (April 2014 - March 2015) medical fee revision briefing, Japan's Ministry of Health, Labour and Welfare (MHLW) announced changes to its strategy for generic drug promotion, through which it seeks to increase...
View full press release